Pibrentasvir and Impurities
Ref: 4Z-P-363006
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-P-363004
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-P-363008
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-P-363007
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
ABT530
CAS:1353900-92-1
ABT530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV …
Formula:
C57H65F5N10O8
Purity:
99.73% - 99.73%
Color and Shape:
Solid
Molecular weight:
1113.18
Ref: TM-T5127
10mg | 48.00 € | ||
25mg | 89.00 € | ||
50mg | 126.00 € | ||
100mg | 187.00 € | ||
1mL*10mM (DMSO) | 53.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-P-363003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-P-363001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-P-363005
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-P-363002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025